AMT's Cooperative Research and Development Agreement With NIH to Boost Productio... (rapies to benefit far larger patient gro...)

AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity

Date:5/25/2008

rapies to benefit far larger patient groups than was hitherto thought possible. In addition, it would allow us to attempt the treatment of diseases that require the systemic (as opposed to local) expression of therapeutic genes. Duchenne Muscular Dystrophy is such a disease, and together with La Sapienza in Rome we will work very hard to develop a treatment for this wasting disorder for which there is currently no treatment."

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's b
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. NASA Extends Cooperative Agreement With NSBRI
2. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
3. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
4. DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement
5. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
10. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
11. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience

Post Your Comments:

(Date:6/19/2013)... Bellevue city councilmember John Stokes will ... for people with disabilities on Friday, June 21 ... , The exhibit hall, which is free and ... will feature leading manufacturers and suppliers of assistive ... technologies, computer applications, and home modification equipment. Local ...

(Date:6/19/2013)... , June 19, 2013 U.S. Secretary of ... ceremony at which distinguished Syngenta scientist Mary-Dell ... prestigious 2013 World Food Prize. The prize is the ... development by improving the quality, quantity or availability of ... two other laureates were recognized for "revolutionary biotechnology discoveries ...

(Date:6/19/2013)... Clinverse, Inc. , a ... trials, today announced it will be exhibiting and ... in Boston, June 24-26, 2013. Clinverse’s eClinical ... fully configurable, cloud-based clinical financial lifecycle system. , ... Clinverse’s eClinical Commerce Network, automates site contract set-up ...

(Date:6/19/2013)... , June 19, 2013 MO BIO ... and other challenging microbial nucleic acid purification, announces ... Kit, for extraction of pure protein from all ... coincides with the 20 th anniversary of ... capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...

Breaking Biology Technology:City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2 Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2 Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2 MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2

[0] City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall [0] Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate [0] Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 [0] MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil

... K. H. Valkonen*, N. Marttinen*, H.-L. Malinen*, V.-P. Jaakola** and , ... , * Biotechnology Laboratory, REDEC of Kajaani, University ... ** Department of Biological and Environmental Science, University of Jyvskyl, , ... , Introduction , ...

... Contributed by Philip W Miller, Waltraud I Dunn, and Robert R Schmidt, , ... FL 32611 USA , ... , Introduction , ... elucidate the pre- , and posttranslational mechanisms that regulate ...

... Introduction , ... or probes in genetic analysis. Quality control of these preparations ... electrophoresis or HPLC, but these , methods may ... not provide desired quantitative precision or automation. Capillary electrophorsis , ...

Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing Preparative Nondenaturing Gel Electrophoresis to Purify NADP-Specific Glutamate Dehydrogenase From Chlorella, Rev B Oligonucleotide Purity Analysis by Capillary Electrophoresis

(Date:6/19/2013)... The Microbial Diversity Course at the Marine Biological ... a Milestones in Microbiology site by the American ... in Microbiology program recognizes institutions and the scientists ... toward advancing the science of microbiology. A ... site is scheduled for Saturday, June 22, 2013, ...

(Date:6/19/2013)... , June 19, 2013 MedNet Solutions ... clinical study management systems, is pleased to announce its ... held June 23-27 in Boston . ... a recognized leader in cloud-based eClinical solutions, has exhibited ... be showcasing iMedNet™ EDC , MedNet,s ...

(Date:6/19/2013)... 19, 2013 New York College of Health Professions ... Patent and Trademark Office for detecting biometric changes through ... guards have been injured, attacked or killed. ... the Intellectual Properties Agreements of New York College of ... of New York College says, ...

Breaking Biology News(10 mins):Microbial diversity course designated as a 'Milestones in Microbiology' site 2 MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2 New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2 New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3 New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4

[0] Microbial diversity course designated as a 'Milestones in Microbiology' site [0] MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting [0] New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed

... from Huntsman Cancer Institute (HCI) at the University ... to identify cancer-causing rearrangements of genetic material called ... of the method and the research results appear ... Molecular Medicine journal. Many cancers result from ...

... diseases might soon have another warrior to contend with, thanks ... of Illinois. The new antibiotic, an analog of the widely ... boon to the dairy industry as a treatment for bovine ... product of bacteria resident in the cow,s udder. It helps ...

... may have discovered how memories are encoded in ... strengthened synaptic connections among neurons. However components of ... while memories can last a lifetime. Based ... lead researcher Jack Tuszynski, his graduate student Travis ...

Cached Biology News:Beyond the microscope: Identifying specific cancers using molecular analysis 2 New antibiotic could make food safer and cows healthier 2 New antibiotic could make food safer and cows healthier 3

Beyond the microscope: Identifying specific cancers using molecular analysis New antibiotic could make food safer and cows healthier University of Alberta led research may have discovered how memories are encoded in our brains

Purified anti-PXR...

Request Info...

Mouse monoclonal [2991] to C3a / C3a des Arg ( Abpromise for all tested applications). SwissProtID: P01024...

Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....

Biology Products:

Rabbit Anti-PXR (Poly6169) Polyclonal Antibody, Unconjugated from BioLegend Acridinium Quench Solution from Cayman Chemical Mouse Anti-C3a / C3a des Arg Monoclonal Antibody, Unconjugated, Clone 2991 from Abcam Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam